BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 1380372)

  • 1. Identification of inhibitors of nitric oxide synthase that do not interact with the endothelial cell L-arginine transporter.
    Bogle RG; Moncada S; Pearson JD; Mann GE
    Br J Pharmacol; 1992 Apr; 105(4):768-70. PubMed ID: 1380372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective targeting of nitric oxide synthase inhibitors to system y+ in activated macrophages.
    Baydoun AR; Mann GE
    Biochem Biophys Res Commun; 1994 Apr; 200(2):726-31. PubMed ID: 7513994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of endothelial cell amino acid transport systems involved in the actions of nitric oxide synthase inhibitors.
    Schmidt K; Klatt P; Mayer B
    Mol Pharmacol; 1993 Sep; 44(3):615-21. PubMed ID: 7690451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of neuronal amino acid transporters: uptake of nitric oxide synthase inhibitors and implication for their biological effects.
    Schmidt K; List BM; Klatt P; Mayer B
    J Neurochem; 1995 Apr; 64(4):1469-75. PubMed ID: 7534332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo.
    Rees DD; Palmer RM; Schulz R; Hodson HF; Moncada S
    Br J Pharmacol; 1990 Nov; 101(3):746-52. PubMed ID: 1706208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of nitric oxide synthase inhibitors by macrophage RAW 264.7 cells.
    Schmidt K; Klatt P; Mayer B
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):313-6. PubMed ID: 7519006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine transport in human liver. Characterization and effects of nitric oxide synthase inhibitors.
    Inoue Y; Bode BP; Beck DJ; Li AP; Bland KI; Souba WW
    Ann Surg; 1993 Sep; 218(3):350-62; discussion 362-3. PubMed ID: 7690540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of N-iminoethyl-L-ornithine as an irreversible inhibitor of nitric oxide synthase in phagocytic cells.
    McCall TB; Feelisch M; Palmer RM; Moncada S
    Br J Pharmacol; 1991 Jan; 102(1):234-8. PubMed ID: 1710525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic characteristics of nitric oxide synthase from rat brain.
    Knowles RG; Palacios M; Palmer RM; Moncada S
    Biochem J; 1990 Jul; 269(1):207-10. PubMed ID: 1695842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of inhibitors of nitric oxide synthase in immune complex-induced vasculitis.
    Mulligan MS; Moncada S; Ward PA
    Br J Pharmacol; 1992 Dec; 107(4):1159-62. PubMed ID: 1281719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairment of osteoblast growth by nitric oxide synthase inhibitors: an effect independent of nitric oxide and arginine transport inhibition.
    Riancho JA; Zarrabeitia MT; Salas E; González-Macías J
    Methods Find Exp Clin Pharmacol; 1996 Dec; 18(10):663-7. PubMed ID: 9121222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the L-arginine:nitric oxide pathway in human platelets.
    Radomski MW; Palmer RM; Moncada S
    Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction by NG-nitro-L-arginine of H2O2-induced endothelial cell injury.
    Shimizu S; Nomoto M; Yamamoto T; Momose K
    Br J Pharmacol; 1994 Oct; 113(2):564-8. PubMed ID: 7530574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible inactivation of endothelial nitric oxide synthase by NG-nitro-L-arginine.
    Mayer B; Schmid M; Klatt P; Schmidt K
    FEBS Lett; 1993 Oct; 333(1-2):203-6. PubMed ID: 7693510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acids differentially inhibit the L-[3H]arginine transport and nitric oxide synthase in rat brain synaptosomes.
    Lopes MC; Cardoso SA; Schousboe A; Carvalho AP
    Neurosci Lett; 1994 Nov; 181(1-2):1-4. PubMed ID: 7534888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed gastric emptying induced by inhibitors of nitric oxide synthase in rats.
    Plourde V; Quintero E; Suto G; Coimbra C; Taché Y
    Eur J Pharmacol; 1994 Apr; 256(2):125-9. PubMed ID: 7519557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional expression of three isoforms of human nitric oxide synthase in baculovirus-infected insect cells.
    Nakane M; Pollock JS; Klinghofer V; Basha F; Marsden PA; Hokari A; Ogura T; Esumi H; Carter GW
    Biochem Biophys Res Commun; 1995 Jan; 206(2):511-7. PubMed ID: 7530001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrogenic arginine transport mediates stimulus-secretion coupling in mouse pancreatic beta-cells.
    Smith PA; Sakura H; Coles B; Gummerson N; Proks P; Ashcroft FM
    J Physiol; 1997 Mar; 499 ( Pt 3)(Pt 3):625-35. PubMed ID: 9130159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism.
    Leibovich SJ; Polverini PJ; Fong TW; Harlow LA; Koch AE
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4190-4. PubMed ID: 7514298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis.
    MacAllister RJ; Fickling SA; Whitley GS; Vallance P
    Br J Pharmacol; 1994 May; 112(1):43-8. PubMed ID: 7518309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.